chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joint pain after the vaccine all over body, knees, hands, knuckles, elbow, ankle, toes, wrist, arm; ached all over; This is a spontaneous report from a contactable nurse. A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EK4176, via an unspecified route of administration on 14Jan2021 11:30 at a single dose on the right arm for COVID-19 immunization. Medical history included hypertension, vitamin d deficiency and COVID-19. The patient is not pregnant and had no known allergies. The patient had no other vaccines in four weeks.The patient's concomitant medications were not reported. The patient experienced joint pain after the vaccine all over body, knees, hands, knuckles, elbow, ankle, toes, wrist, arm. She ached all over. The events started on 14Jan2021 21:00 and there were no treatment received. The patient recovered from the events on Jan2021. The patient underwent lab tests and procedures which included Covid test post vaccination: unknown results.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Reporter stated that no treatment was given to patients.  Reporter also stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
Itchy throat 15 mins after receiving 3rd Anthrax shot. Pt c/o tingling and itching in throat and SOB s/p Anthrax immunization. She states she had similar, very slight sx's post 2nd Anthrax imms, but dismissed it. Given Epinephrine inj. immediately post start of sx's. Pt was having none of the above sx's within 15 mins of epi administration. Currently c/o feeling "flushed." CV mild tachycardia. Possible anaphylaxis to Anthrax 3rd injection. Pt released post monitoring for 2 hrs without sx's. Instructed to return or go to ER if sx's rreturns orr prn. No more Anthrax imms for this pt.
Information has been received from an office manager referring to an unspecified number of patients of unknown age and gender. On unspecified dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (lot # L014429, expiration date 15-MAR-2018 and/or lot# K019700, expiration date 16-JUL-2017, dose and route not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Severe rash. Treated at ER with prednisone and recommended Benadryl.
From initial information received on 11/5/04 from the patient who is a physician regarding an adverse event occurring in the USA, it was reported that he, a 74 year old male, received a FLUZONE vaccination, lot number U1381AA, administered on 10/14/04. Two days after the vaccination the patient developed a headache which persists to the present and radiates to his left eye. The patient was seen by an ophthalmologist and diagnosed with third cranial nerve palsy left sided. The patient recovery status is listed as unknown. (OMIC)
~24 hours after vaccine administration hives started on child's hand & progressed all over his arms, legs & chest with in 1 hour. Hives red & hot but not itching. Family treated with BENADRYL 10/20/09 at 8:30pm, 10/21/09 at 8:30am & 1:30pm but rash remains. Child also had Aveeno bath on 10/20/09. Recent development of a barking like cough in PM of 10/20/09.
shot administered 13:20. within 10 minutes, pt reported itchy throat & was given bottle of water. pt was given benadryl 25mg at 13:45, symptoms did not improve. pt reported feeling of a growing lump in her throat. epi-pen was given at 14:00.  medic responded. pt given additional 25 mg benadryl and released to medic. 911 was not called
On 03/21/02, the vaccinee who "had not eaten anything all day" was vaccinated with an injection of Twinrix; the number of previous Twinrix injections was not reported. Approximately five minutes post-immunization, the vaccinee felt faint and experienced sweating and dizziness. Blood pressure in her left arm was 100/60 mm Hg; blood pressure  in her right arm was 110/70 mm Hg. the vaccinee's baseline blood pressure was not reported she was observed for ten minutes and recovered fully, without treatment.
Fever spiked up to 102 degrees and then he had a febrile seizure that lasted 2 minutes.  Taken to local ER and told he had a small ear infection and minor viral pneumonia.
Broke out in a rash on the neck and chest. Travelled down to hips. Excruciating abdominal pain
- 04.07 & 04.08, Intense pain in the left arm, at injection site. - 04.10 & 04.11, Chills. Pain in my neck & shoulder area extending to middle back. - 04.12, Numbness in my right hand started (sought medical help after that). - 04.16, Appointment at my regular doctor clinic. Reported soreness at the injection site, swelling, itchiness and rash, and as well as numbness on my right hand, affecting mostly, thumb, index & middle fingers. I was prescribed Ibuprofen (600 mg/day 7 days)   - 04.23, Follow up appoint. Upper back and left shoulder pain still present. Numbness & intense hot/cold feeling in index & middle fingers. X-ray done & Physiotherapy started. - 05.01, Numbness unresolved (index & middle fingers).
12 hours after the injection I had chills, body aches sweating and a strong pain in my left armpit.  I continued taking Tylenol and Advil every 6 hours to eas e the pain . My symptoms have slowly gotten better but have been continuous for 60 hours. At around 48 hours I did have a low grade fever. Last night the body aches were not as bad but I did have night sweats and an extremely painful swollen left armpit.
2 weeks PTA had flu shot and developed fever/chills, resolved w/ medication. 1-2 weeks PTA developed fatigue and headaches. 5 days PTA awoke with numbness in fingers and toes. Presented w/ worsening neuropathy and weakness. Admitted and diagnosed w/ Guillain Barre. Pt pain managed w/ medication and treated w/ 5 days IVIG. Improved substantially and discharged.
The symptoms I describe began before Tuesday, June 29 but on that everything got much worse and each day it gets more noticeable and worse.  I noticed an EXTREME increase in my inability to think clearly.  I get confused easily, I forget work items to complete, I forget to call people.  When I'm typing, I'm striking the wrong keys throughout the day, several times per hour.  I'm not speaking clearly or making sense.  I have more difficulty listening.  Just writing this report, I'm having trouble typing (I've made at least 20 errors trying to hit the correct keys) and I'm not able to write clearly.  People have noticed and I'm worried about my job because I'm making too many mistakes.  I'm scared.
lower back spasm -lasted 3 days even with steroids, pain medication and muscle relaxers, unable to move lower extremities, vomitting due to pain,  after three days in hospital for the for one month after still continued with  periodic spasms. Physical therapy twice a week little relief. The very next day after the second vaccine had another major attack that with same symptoms. Went to physiatrist linked the lyme and vaccine, placed me on cerebrex and in a little over a week I was able to go one day without any spasms and pain for the first time in over a month.
Started having upper abdominal pain and then a couple of weeks later started with diarrhea. Was planning on traveling so went to physician to get tested and to do lab work for symptoms.Labs included liver enzymes. ALT and AST were somewhat elevated and Alk Phos was very elevated. Later, on 6/11/2021, had an abdominal ultrasound which did not show signs of fatty liver disease or any obvious problems with bile ducts or portal veins. Liver enzymes, as of, 5/21/2021, were ALT 57, AST 49, and Alk Phos 615. These labs will be repeated on 7/12/2021.
USE OF VACCINE OUTSIDE OF RECOMMENDED STORAGE TEMPERATURE; ADMINISTERED VACCINE THAT WAS AT ROOM TEMP FOR 4 HOURS; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: UNKNOWN) dose was not reported, administered on 10-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-JUN-2021, the subject experienced out of specification product use. On 10-JUN-2021, the subject experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the out of specification product use and incorrect product storage was not reported. This report was non-serious.
Parent Denies adverse Reaction R/T wrong dose given 0.5ml instead of 0.3ml
This spontaneous report as received from a registered pharmacist refers to a 60 year old female patient with no pertinent medical history and no drug reactions or allergies. On 13-SEP-2013, the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (Lot # J001698 expiration date 08-MAY-2014) subcutaneously. Concomitant therapies included unspecified "beta blocker". The pharmacist reported that the patient's husband reported to him that on an unknown date, the patient experienced a red, itchy area at the injection site. At the time of the report, the patient had not recovered. This is one of several reports received from the same source. Additional information has been requested.
Approx 10 mins after Fluvirin shot and 20 mins after Kenalog Marcaine left shoulder intra articular injection. Pt had SOB,hive like rash,itching, syncope and near loss of consciousness, given O2, IV fluids, Benadryl, SQ epi, Solu Medrol, shoulder pain, decreased range of motion. Pain keeping PT awake at night. Prior to administration pt was lightheaded an slumped to floor. Pt was layed on floor, Pt semi alert no LOC. Small amount of clean emesis, O2 given by facemask, then Benadryl and EPI given. Then Pt lifted to wheel chair taken to BM9. IV was started O2 sat 93. Monitor put on. Low BP noted PVC and Decreased HR if sat up. So Pt was maintain in supine position 600-700 cc IV saline Solu, No wheezing. mild decreased in rash. Given Solumedrol and transported to ER in ambulance. A & O x3 and talking.
3-4 in raised erythematous uncomfortable lesion at injection site of Dtap. Mom noted on 12/5/19.
Immunizations administered 2/21/08.  No fever at that time.  However, had congestion, sneeze, cough.  Amoxicillin started for 10 days.  Mother called 2/25/08 - complained of fever 102 that night, took 2 days to break fever.  Patient is now very irritable.  Mother is questioning if this is a reaction to shots and would like to discuss with doctor.  2 attempts to call mother back - phone line busy.  Reached mother at 5:10 PM - said she would call for same day appointment next day if not any better.  Mother called 2/26 - took patient off antibiotic and he's fine now.  Sleeping - no vomiting - no crying.  Next visit 4/7/08 complained of not sleeping through night - choking on liquids.  Questioning if from immunization.
BACK PAIN; SWEATS (SOAKED BED SHEETS); FEVER TO 103F; FATIGUED; This spontaneous report received from a parent via a company representative concerned a 20 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 23-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 23-JUL-2021, the subject experienced sweats (soaked bed sheets). On 23-JUL-2021, the subject experienced fever to 103f. On 23-JUL-2021, the subject experienced fatigued. Laboratory data included: Body temperature (NR: not provided) 103 F. On 24-JUL-2021, the subject experienced back pain. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from back pain, sweats (soaked bed sheets), fever to 103f, and fatigued on 25-JUL-2021. This report was non-serious.
painful shots, hurt; This case was reported by a consumer and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The patient stated that the first shingles shots really hurt, and it would worth the painful shots. The second was no problem at all. Then the patient got two Moderna shots. It was so easy, and the patient asked why do people make such a big deal out keeping themselves and others safer. The follow-up would not possible as no contact details were available.
The vaccine shot was given a little high in the left shoulder but not high enough to involve the bursa joint capsule. There was no frozen joint type of event. The needle did not cause severe initial pain or bleeding. I do not believe the syringe was drawn back to see if it was in a blood vessel. Later that day and the following day there was the usual mild soreness at the injection site. This soon went away. About two weeks later there was severe pain about 10 centimeters below the injection site. The pain was intermittent and migratory in the upper and lower left arm. The migratory pain was dependent on arm position and would leave one area to go to another. There was no palpable mass or heat or discoloration. No weakness except due to the pain. No tenderness to touch nor fever. Pain is severe and debilitating. Pain continues at a severe level.
Dizziness, Headache, Myalgia, Fever &  NauseaVomiting Narrative:
received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 1-year-old patient who received Hib (Hiberix) (batch number 242A7) for prophylaxis.   On 13-JAN-2023, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Fever-+39 degrees Celcius, and I had never experienced even a headache before I took the vaccine. Severe arm pain-Almost like a broken arm  Luckily, I am better at day #2. Very grateful that I took the vaccine, and the US gave me the opportunity to do so.  However, to contribute to research and data, I wanted to report what I experienced.
Redness, swelling - seen at ER.  Reaction happened on weekend, so patient went to ER.
Slow swelling of lymph nodes in neck following by sinus congestion,  headaches, and TMJ. Ears became full with fluid and pressure then extreme tinnitus developed.  My regular doctor prescribed 2 different antibiotics which had zero effect on tinnitus. It is  almost 12 weeks after the tinnitus began and I still have ringing in the ears. It has reduced to 50% over the 3 months. I have never experienced this symptom previously and it has become the worst health event in my life.  I have not been exposed to any loud sounds. I have been to see 2 ENTs and they believe the condition is permanent. I had a CT scan completed and it shows there are no issues. I am hoping it is inflammation and will go away over time.   I am currently taking Prednisone and hoping it reduces any possible inflammation.  The ringing and popping noises in my ears need to stop ASAP.
knot under the skin around the site of injection which is hot to touch; started to hurt again; redness and splotchiness on his arm below his elbow; Redness; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), RASH MACULAR (redness and splotchiness on his arm below his elbow), VACCINATION SITE REACTION (knot under the skin around the site of injection which is hot to touch), VACCINATION SITE PAIN (arm soreness) and VACCINATION SITE PAIN (started to hurt again) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced ERYTHEMA (Redness) and VACCINATION SITE PAIN (arm soreness). On 14-Apr-2021, the patient experienced RASH MACULAR (redness and splotchiness on his arm below his elbow). On 20-Apr-2021, the patient experienced VACCINATION SITE REACTION (knot under the skin around the site of injection which is hot to touch) and VACCINATION SITE PAIN (started to hurt again). The patient was treated with IBUPROFEN for Pain in arm, at an unspecified dose and frequency. On 15-Apr-2021, RASH MACULAR (redness and splotchiness on his arm below his elbow) had resolved. On 16-Apr-2021, ERYTHEMA (Redness) and VACCINATION SITE PAIN (arm soreness) had resolved. At the time of the report, VACCINATION SITE REACTION (knot under the skin around the site of injection which is hot to touch) and VACCINATION SITE PAIN (started to hurt again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Pt. developed chest tightness which she described as her usual feeling when needing her rescue inhaler for asthma about 5 minutes post vaccination, had felt very anxious prior to vaccine due to needle phobia. She denied any associated symptoms either cardiac or respiratory system related and no localized arm pain at the injection site. She was also fatigued having worked since 5AM as a medical screener at a nearby clinic and had not eaten in more than 8 hours
Cont screaming & crying for 3 or more hrs. Mother reported T of 104 @ home. T @ clinic rechecked 99.3. Swelling & redness of rt thigh.
This spontaneous report was received from a registered nurse and refers to a 12-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 26-DEC-2018, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot # 1586752, expiration date 16-FEB-2021 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient).; Sender's Comments: US-009507513-1901USA000071:
Rash lower back, itching on back, leg, lower stomach.; Rash lower back, itching on back, leg, lower stomach.; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246) solution for injection, via an unspecified route of administration on left arm on 07Jan2021 17:15 at a single dose for COVID-19 immunization. Medical history included hypertension, kidney disease stage 3, UTI (urinary tract infection), enlarged prostate, and known allergy to penicillin. Concomitant medication included amlodipine, benazepril, tamsulosin, ergocalciferol (VIT D), and unspecified multivitamin. The patient experienced rash lower back, itching on back, leg, lower stomach on 09Jan2021 at 2pm. No treatment received. The events were reported as non-serious. The patient was not diagnosed with Covid-19 prior to vaccination. The patient has not been tested for Covid-19 since the vaccination. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 8/22/2023 Discharge Date: 08/28/2023  Discharge Disposition: Home DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shortness of breath   HOSPITAL COURSE: Patient is a 83-year-old female who was admitted on 08/22/2023 for worsening shortness of breath and cough.  She had been treated outpatient for these symptoms the past 11 days prior to admission with doxycycline, cefdinir, and prednisone.  Initially patient was meeting sepsis criteria and was requiring up to 10 L of oxygen on high-flow.  COVID-19 was positive.  Patient also had electrolyte abnormalities and was given IV magnesium and potassium four repletion.   During admission patient has been treated with Decadron (8/222 present) will continue for 3 more days to complete a 10 day course treatment.  Oxygen has been reduced to 2 L at rest 24/7 this is an increase from her baseline which is 2 L nocturnal and with activity.  Home health care will assist in weaning this.  PT and OT to see at home.  We will also send p.r.n. Tessalon Perles and Mucinex. She does have slight crackles to bilateral bases today on exam and she did not want to work with therapy due to shortness of breath.  Patient states though she feels significantly improved and wants to discharge.  She is on Lasix and I advised that she stick to a 2 L fluid restriction.  Will also have her finish 3 days of doxycyline, that was prescribed before admission.
She has chills; Body pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "she has allergies to some medications" (unspecified if ongoing); "Some things and had strong allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "She has chills"; PAIN (non-serious), outcome "unknown", described as "Body pain".  Additional information: The patient had allergies to some medications and some things and had strong allergies and spoke with someone that Pfizer vaccines didn't ask anything that she couldn't have it. She had chills and body pains and wanted to know if the 4 dose had the same things as the first 3 vaccines.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201282774 Same patient/product/events, different dose;US-PFIZER INC-202201282775 Same patient/product/events, different dose;